Ellodi Pharmaceuticals
Manufacturing · Pennsylvania, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
325 Sentry Pkwy Bldg 5 Ste 200, Blue Bel...Phone Number
(888) 335-5634Website
www.ellodipharma.comRevenue
$7 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Ellodi Pharmaceuticals
Ellodi Pharmaceuticals is a specialty pharmaceutical company focused on gastroenterology, specifically developing novel therapies for the treatment of Eosinophilic Esophagitis. The company is engaged in research and clinical studies, including the FLUTE 3 Study, to advance its pipeline of treatments. Intended clients include patients suffering from Eosinophilic Esophagitis and patient advocacy groups. Ellodi Pharmaceuticals aims to provide innovative solutions to improve patient outcomes in this area.Explore more
Ellodi Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Ellodi Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Ellodi Pharmaceuticals
Check out if Ellodi Pharmaceuticals is spiking on competitors!
Ellodi Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Click to see if Ellodi Pharmaceuticals had a recent Job posting/layoffs
Earning: See what the market has to say on Ellodi Pharmaceuticals recently announced quarterly report
Check if Ellodi Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Ellodi Pharmaceuticals launches new products
Funding: Get notified immidiatlly once Ellodi Pharmaceuticals has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Ellodi Pharmaceuticals
Compare insights from companies similar to Ellodi Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$7.2M
11-50
Private
-
-
Company Profile Activity
Activity Insights
Ellodi Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Ellodi Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Ellodi Pharmaceuticals.
Ellodi Pharmaceuticals Tech Stack
A closer look at the technologies used by Ellodi Pharmaceuticals
See more technologies
Ellodi Pharmaceuticals News & Media
Ellodi Pharmaceuticals Welcomes Debra Silberg MD, PhD, FACG to its Board of Directors
BLUE BELL, Pa.--(BUSINESS WIRE)--Ellodi Pharmaceuticals, a gastroenterology-focused specialty pharmaceutical company dedicated to the continued development of APT-1011, a novel, investigational oral therapy for the treatment of Eosinophilic Esophagitis (EoE), announced today that Debra Silberg, MD, PhD, FACG has joined the company’s board of directors. Dr. Silberg will also serve as a Scientific Advisor. Dr. Silberg is an accomplished life sciences executive with deep experience across all stag
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Ellodi Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Ellodi Pharmaceuticals is a specialty pharmaceutical company focused on gastroenterology, specifically developing novel therapies for the treatment of Eosinophilic Esophagitis. The company is engaged in research and clinical studies, including the FLUTE 3 Study, to advance its pipeline of treatments. Intended clients include patients suffering from... Read More
